Recorded presentation

Rosanna M. Coffey, PhD¹, Rita Vandivort-Warren, ACSW², Tami L. Mark, PhD³, Henrick Harwood⁴, Joan D Dilonardo, PhD⁵, Ellen Bouchery⁴, Edward C King⁶, Jim Genuardi⁷, and David McKusick, PhD⁷. (1) The Medstat Group, 4301 Connecticut Avenue, NW, Washington, DC 20008, 202-719-7822, Rosanna.Coffey@Medstat.com, (2) Division of Policy Coordination, OPPB, OA, Substance Abuse & Mental Health Services Adm., HHS, 5600 Fishers Lane, Room 10-99, Parklawn Bldg, Rockville, MD 20857, (3) Outcomes Research and Econometrics, Medstat, 4301 Connecticut Avenue, NW, Washington, DC 20008, (4) The Lewin Group, Inc, 3130 Fairview Park Drive, Suite 800, Falls Church, VA 22042, (5) Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, Rockwall II Building, Suite 740, 5515 Security Lane, Rockville, MD 20852, (6) Actuarial Research Corporation, 5513 Twin Knolls Road, Suite 213, Columbia, MD 21045, (7) The Actuarial Research Group, 5513 Twin Knolls Road, Suite 213, Columbia, MD 21045

OBJECTIVE: In this presentation the audience will learn how substance abuse treatment payment sources have changed from 1991 to 20001. METHODS: The study employed numerous nationally representative databases and statistical and actuarial methods to develop estimates of expenditures by payer type. Estimates are available by: private insurance, out-of-pocket, Medicare, Medicaid, other state and local government, and the Federal government. Trends are examined from 1991 to 2001. Payer distributions within specific types of providers are also available. RESULTS: From 1991 to 2001, SA expenditures grew at 6.4% annually compared to a growth rate of 6.5% for all health. In 1991, public sources made up 62% of total SUD treatment spending, while in 2001, they were 77%. Private insurance SUD treatment expenditures actually declined, with -0.1% annual decline between 1991 and 2001. Within specialty substance abuse centers there has been a growth in funding from state and local governments and a decline in Federal funding. CONCLUSIONS: Funding sources for SUD treatment have changed in important ways over the past decade.

Learning Objectives:

• In this presentation the audience will learn which types of payers funded SUD treatment and how payment sources have changed over time

Presenting author's disclosure statement:
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.

Recorded presentation